Physician

Adnan Akhtar, MD

According to 2025 Medicare claims, Adnan Akhtar, MD (NPI: 1366404642) practices hematology/oncology in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Osceola, FL. This provider's primary affiliated billing organization is FLORIDA HOSPITAL MEDICAL GROUP INC (NPI: 1225034234; TIN: 593214635) and primary practice location at 34747-4606.

Akhtar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 459 traditional Medicare patients, billed 1,418 HCPCS/CPT codes, and received $78,295 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 2,399 prescription claims across 513 beneficiaries totaling $8,049,399 in drug costs, led by Pomalyst (Pomalidomide). 2023 DME data shows 28 claims. Open Payments data shows 14 records totaling $582. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,040,924 to $8,049,399. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	536	3,725	$108,530
2016	439	3,109	$88,866
2017	505	3,140	$100,233
2018	559	3,080	$91,238
2019	598	2,581	$94,102
2020	602	2,261	$89,465
2021	532	1,860	$86,456
2022	558	1,512	$91,189
2023	506	1,547	$92,882
2024	459	1,418	$78,295

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	226	1,120	$2,040,924
2016	224	1,221	$2,768,002
2017	262	1,302	$2,831,749
2018	286	1,396	$3,546,554
2019	336	1,437	$3,911,641
2020	365	1,737	$4,949,403
2021	389	1,512	$4,649,359
2022	423	1,762	$6,096,981
2023	447	2,064	$6,845,944
2024	513	2,399	$8,049,399

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	14	$16,615
2016	N/R	N/R	N/R
2017	N/R	45	$15,652
2018	N/R	40	$6,296
2019	N/R	N/R	N/R
2020	N/R	33	$2,418
2021	N/R	66	$4,318
2022	N/R	28	$953
2023	N/R	28	$8,592
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	86	95	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	275	500	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	57	68	$58
36415	Insertion of needle into vein for collection of blood sample	158	218	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	248	407	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	68	1,785	$1,393,189
Ibrance	Palbociclib	83	2,303	$1,329,870
Lenalidomide	Lenalidomide	48	1,344	$732,926
Venclexta	Venetoclax	58	1,690	$663,385
Truqap	Capivasertib	27	758	$611,447

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$582	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adnan Akhtar, MD?

Tedicare shows public-source Medicare data for Adnan Akhtar, MD (NPI 1366404642), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adnan Akhtar, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adnan Akhtar, MD?

Adnan Akhtar, MD is linked to FLORIDA HOSPITAL MEDICAL GROUP INC (billing NPI 1225034234) in the available physician profile data.

Does Adnan Akhtar, MD have Open Payments data?

Adnan Akhtar, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.